Objective
Substantial progress have been made in the clinical description, predisposing factors and pathological features of RT-induced late cognitive dysfunction after conventional cerebral RT. For the first time, an experimental model of this syndrome has been developed which should be useful to understand its pathogenesis.
An acute model of cognitive dysfunction after whole body irradiation has been developed which seems quite useful to test radioprotective agents. In the future we hope to try these radioprotective agents in the chronic model.
THE RESEARCH PROJECT CONCERNS I)THE STUDY OF PATHOLOGICAL, PHYSIOLOGICAL, AND BIOCHEMICAL PARAMETERS, ON CLINICAL OR EXPERIMENTAL MATERIAL, IN ORDER TO DEFINE THE EVOLUTIVE POTENTIAL OF RADIATION INDUCED DAMAGE TO THE VASCULAR AND CONNECTIVE OR SUPPORTIVE TISSUES TISSUES IN VARIOUS ORGANS, II) THE DEVELOPMENT OF PARACLINICAL TESTS FOR DIAGENOSIS AND THE EVALUATION OF SEVERAL PHARMACOLOGICAL APPROACHES TO PREVENT AND/OR TREAT THESE DAMAGES AFTER ACCIDENTAL IRRADIATION. THE ORGANS CONSIDERED WILL BE THE LUNG (PARTIAL BODY), LENS, OSSEOUS AND TENDINOUS TISSUES, MUSCLES, VASCULAR TISSUE AND GLIAL CELLS IN THE CENTRAL NERVOUS SYSTEM (CNS). THE BIOLOGICAL AND EXPERIMENTAL APPROACH WILL FOCUS ON THE CHARACTERIZATION OF PARACRINE REGULATIONS BETWEEN MESENCHYMATOUS AND EPITHELIAL CELLS (CHEMICAL MEDIATORS, HORMONES, CYTOKINES AND GROWTH FACTORS) AND ON MECHANISMS OF TISSUE POROTECTION BY SEVERAL COMPOUNDS. THE THERAPEUTIC APPROACH ENVISAGES THE LOCAL ADMINISTRATION OF PHARMACOLOGICAL COMPOUNDS CAPABLE TO PREVENT OR TO TREAT THE CONSEQUENCES OF ACUTE OVEREXPOSURES TO IONIZING RADIATIONS IN ACCIDENTAL SITUATIONS. VARIOUS MODALITIES OF ADMINISTRATION OF COMPOUNDS KNOWN TO REVERSE THE POST IRRADIATION FIBROTIC EVOLUTION, SUCH AS SUPEROXYDE DISMUTASE (SOD), WILL BE DEVELOPED ACCORDING TO THE TARGET ORGANS: AEROSOLS FOR FOR LUNG FIBROSIS, TRANS CUTANEOUS INFUSION FOR DEEP LESIONS, ETC...) AND EVALUATED WITH OBJECTIVE CLINICAL AND PARACLINICAL INDICES. THE ACHIEVEMENTS EXPECTED FROM THIS PROJECT ARE I) A BETTER ASSESSMENT OF THE EVOLUTIVE POTENTIAL OF RADIATION INDUCED FIBROSIS, SCLEROSIS, THROMBOSIS AND NECROSIS AND ASSOCIATED PATHOGENESIS (PHYSIOPATHOLOGY, DIAGNOSIS, PROGNOSIS) AND II) AN EVALUATION OF DIFFERENT TREATMENTS TO PREVENT, REVERSE OR LIMIT THE PROGRESSION OF VARIOUS PROCESSES.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences neurobiology
- medical and health sciences clinical medicine angiology vascular diseases
- natural sciences physical sciences nuclear physics
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Data not available
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
92260 Fontenay-aux-Roses
France
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.